A brand-new look!

We are excited to announce that Julius Clinical has a brand-new look and website as part of the ongoing evolution of our company’s brand.
Why?
Ever since its foundation in 2008, Julius Clinical has been based on a unique triangle of scientific rigor, operational excellence, and strong site networks. While this remains the core of our company, we have grown and evolved over the past 15 years, and we came to realize that we have become so much more. This is symbolized by the hexagon in our new logo, that surrounds the well-known triangle.
When. Trials. Matter.
Over the past months, we analysed our organization’s values and created a brand identity that reflects those values. Our pay-off: “When.Trials.Matter.” reflects our endless commitment to supporting global clinical drug trials that will have a major impact on medicine and make a real difference to lives all around the world.
A big thank you
The rebranding has been a major process, involving many people from both inside and outside the organisation. We would like to express our appreciation to everyone who has contributed to this process. We could not have done it without you!
What’s next?
Over the coming weeks, the changes will become more and more visible. But for now, we would like to invite you to explore our brand-new website.
Related news
Julius Clinical spoke to obesity expert Professor Liesbeth van Rossum about the multi-factorial, complex and often misunderstood disease and what the future holds
15 April 2025, The NetherlandsJulius Clinical’s Scientific Officer, Associate Professor Manuel Castro Cabezas, interviewed Professor Liesbeth van Rossum, internist-endocrinologist and professor in the field of obesity at the Erasmus MC, Univ...
Recruitment milestone achieved in important Phase II study in Alzheimer’s Disease
Julius Clinical are proud to announce the successful completion of recruitment for the PRImus-AD study, a clinical Phase II study which investigates the safety and efficacy of the drug candidate PRI-002 for the treatment of Alzheimer's Disease....
Julius Clinical Strengthens its European Capabilities by Expanding Operations in Poland
Zeist, Netherlands, [February 25, 2025] – Julius Clinical, a science-driven global CRO specializing in Neurological, Cardio-Metabolic, Renal and Rare Diseases, is pleased to announce the establishment of Julius Clinical Poland, a new operational...